ArticleHaematologica2024

New precision medicine weapons for targeted treatment of high-risk B-cell precursor acute lymphoblastic leukemia.

Sinisa Dovat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.